Israel Financial Insider - Teva was fined 60 million euros by the European Union, in light of an agreement signed between it and Seflon in 2005 and ended in 2011, when Teva
18. Teva Pharmaceutical Industries | FiercePharma
Teva Laying Off Nearly 100 Frazer Employees | Malvern, PA Patch
Teva Pharmaceutical to cut 14,000 jobs, factories in restructuring - UPI.com
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
Teva rejigs top management - Globes
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva to sell Paragard device to CooperSurgical for $1.1bn - Verdict Medical Devices
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva agrees $519m settlement of US anti-bribery charges | Financial Times
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
Teva (TEVA) Stock Is Still Facing Major Risk at This Point | InvestorPlace
Teva Pharmaceutical High Resolution Stock Photography and Images - Alamy
Teva Pharmaceuticals - Wikipedia
Teva rebuffs EU pay-for-delay charge at hearing | Reuters
EU fines Teva for allegedly delaying rollout of cheap sleep disorder drug | The Times of Israel
Teva Stock: Wait And See On This Stock (NYSE:TEVA) | Seeking Alpha
EU antitrust launches probe against Israeli drugmaker Teva
After Multiple Failures, Teva Returns Laquinimod Rights to Active Biotech | BioSpace
Teva Pharma opens $110M plant in Hungary | FiercePharma
Teva appoints Dipankar Bhattacharjee as Prez, CEO Global Generic Group - The Economic Times
Teva: 'Celltrion deal will double biosimilar sales to $600m'
Teva Pharma to sell more women's health assets for $1.38 billion | Reuters
Teva Pharma wins conditional EU approval for Allergan Generics acquisition - IBTimes India
